NCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
Clinical Trials
10 trialsNCT03474601 2020-03-18
SNU-PIT
Seoul National University Hospital
Unknown
NCT03717454 2018-11-20
Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
Ruijin Hospital
Phase NA Unknown
NCT03400865 2018-10-16
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
Ruijin Hospital
Phase NA Unknown
NCT03353025 2017-11-24
TNAPA
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Unknown
NCT02536261 2017-05-16
Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Ruijin Hospital
Unknown
NCT02854228 2016-08-03
PITUICARE-Lyon
Hospices Civils de Lyon
Unknown
NCT01775332 2015-07-31
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Unity Health Toronto
Phase NA Unknown
NCT00598949 2010-12-15
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Cedars-Sinai Medical Center
Unknown
NCT01143584 2010-06-14
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
PIMERIndia
Phase NA Unknown